Skip to content
Proposals to alter Accelerated Approval would reduce number of new treatments, report finds
Plans to put limits on the FDA’s Accelerated Approval pathway would reduce the number of new treatments hitting the market, with a particularly negative […]
Federal Policy
Farm Bill could make things better for biotech
The 2023 U.S. Farm Bill can help drive biomanufacturing by improving federal programs, according to testimony today before the Senate Agriculture Committee, given by
Farm Bill could make things better for biotech Read More »
What we know (so far) the day after the midterms
While midterms results are still being tallied, we know a few key election results—and these results can give us some early insight into the
What we know (so far) the day after the midterms Read More »
CFOs oppose tax change that kills R&D incentives
A letter from 178 CFOs representing major corporations urges legislative leaders to overturn a change in the tax code that would limit deductions for
CFOs oppose tax change that kills R&D incentives Read More »
2022 Midterms Preview: 4 things to watch on Election Day
The midterms are here. And while the days of knowing key race results the evening of Election Day seem to be long gone, it’s
2022 Midterms Preview: 4 things to watch on Election Day Read More »
CMS must flesh out plan to ease out-of-pocket drug costs, report says
Provisions in the Inflation Reduction Act (IRA) make it easier for people covered by Medicare Part D to pay for medicine, but continued government
CMS must flesh out plan to ease out-of-pocket drug costs, report says Read More »
AZBio President: IRA could have ‘long-term, unintended consequences’
The Inflation Reduction Act (IRA), signed into law on August 16, offered historic investments in energy security and climate change. However, the legislation also
AZBio President: IRA could have ‘long-term, unintended consequences’ Read More »
How patient advocates can engage with CMS
On Day 2 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit, a panel titled Implementing Legislation—Engaging CMS dug into the importance
How patient advocates can engage with CMS Read More »
Expanding WTO IP waiver would hurt SMEs, CSBA tells Biden
Every member of the Council of State Bioscience Associations (CSBA) signed a letter to President Biden expressing serious concerns with the proposed expansion of a
Expanding WTO IP waiver would hurt SMEs, CSBA tells Biden Read More »
A new Congress is coming. How can patient advocates engage effectively?
With the midterm elections less than two weeks away, and a new Congress beginning in just about two months, lobbying and educating Members of
A new Congress is coming. How can patient advocates engage effectively? Read More »